The currently available data do not provide evidence that ondansetron use in the first trimester of
[1-4] Use during and after cesarean section appears to not affect the onset of breastfeeding
vomiting during pregnancy and more than 5,800 controls
251 Mothers who took Zofran during pregnancy in Western Australia, 2002–2005
Indications and Usage for Ondansetron ODT
21, 95% CI: 1
4 mg IV/IM immediately before anesthesia or after procedure or 16 mg PO 1 hr before anesthesia; patients >80 kg may need additional 4 mg IV; Acute Gastroenteritis (Off-Label) Routine use is not recommended
The FDA has classified Zofran as a pregnancy class B drug, which means the drug does not appear to cause fetal harm
The drug is also labeled for
6 to 7 large quantity vomits per day is considered normal, also small quantity 10 to 15 vomits per day is also normal
Intravenous ondansetron 4 mg versus placebo was investigated in 16 reports and three further reports which had been duplicated a total of six times
The primary focus of this study is exposure to ondansetron during a pregnancy
After that, take 4 mg every 8 hours for 1 to 2 days after completing chemotherapy
, Reproductive Toxicology (2014) 1349 Infants of women who took Background: Ondansetron is a selective antagonist of the serotonin 5-HT3 receptor that is commonly used to treat morning sickness